Utilisation Trend of Long‐Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Real GDP growth rates and healthcare spending – comparison between the G7 and the EM7 countries2020 · 173 citations
2. 2Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial2020 · 12 citations
3. 3Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants2012 · 23 citations
4. 4European countries with small populations can obtain low prices for drugs: Lithuania as a case history2011 · 77 citations
5. 5Efficacy and safety of MYL‐1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study2018 · 31 citations